Driven Biomarker Discovery and Regulated Manufacturing to Advance Innovative Diagnostic Programs SAN DIEGO, CA / ACCESS Newswire / February 10, 2026 / Calbiotech, Inc. and Liquid Biosciences today ...

Discover the collaboration between Synthace and Charles River to enhance assay development and improve reproducibility in ...

Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug ...

Freeze drying, lyophilization, and cryodesiccation are all terms used to describe the process of removing water from a sample at low temperature. This low-temperature dehydration process maximizes ...

The COVID-19 pandemic and geopolitical conflict in Eastern Europe have done irreparable damage to the underpinnings of the clinical diagnostic industry. These events significantly impacted the supply ...

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide quick results while delivering expected performance and ...

A good bioassay, like a good marriage, joins two partners in a bond and is mutually beneficial. In the case of bioassays, optimal design and development and accurate statistical analysis comprise a ...

Discover advancements in assay development and cell-based screening models with insights on AI, high-throughput screening, and toxicity detection from ELRIG Drug Discovery posters in this eBook.

Collaboration Combines Assay Development, AI-Driven Biomarker Discovery and Regulated Manufacturing to Advance Innovative Diagnostic Programs SAN DIEGO, CA / ACCESS Newswire / February 10, 2026 / Calb ...